Shinji Nakao

25PUBLICATIONS
76CO-AUTHORS
Other Asian languages (excl. South-East Asian)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRegenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 22, 2026
Evidence- and opinion-based consensus from Delphi round 1 of the Asian aplastic anemia recommendation development.

|Jan 04, 2026
Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Fumi Nakamura, Ken Ishiyama, Ritsuro Suzuki

|Sep 08, 2025
Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

Ken Ishiyama, Masahide Yamazaki, Hiroyuki Maruyama

|Aug 04, 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Jong Wook Lee, Jun Ho Jang, Hirohito Yamazaki

|Jul 10, 2025
Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study.

Jong Wook Lee, Jun Ho Jang, Shigeru Chiba

|Apr 22, 2025
Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

Tomoya Maeda, Akira Matsuda, Junya Kanda

Pageof 5

Frequent Collaborators

11 joint publications

Kohei Hosokawa

9 joint publications

Ken Ishiyama

7 joint publications

Hirohito Yamazaki

5 joint publications

Yoshitaka Zaimoku